Oswal Pumps544418Capex expansion plan
Subsidiary board approves 1.2 GW TOPCon solar cell facility; IPO proceeds partly re-directed
Subsidiary board approves a 1.2 GW TOPCon solar cell manufacturing facility.
75%Share of OSEPL cell requirement to be met
- Estimated project cost
- about ₹456 crore
- Capacity approved
- 1.2 GW TOPCon solar cell manufacturing facility
- Commercial production timeline
- expected by April 2028
Project at a glance
- The Board of Directors of Oswal Solar Energy Private Limited (OSEPL), a wholly owned subsidiary, has approved plans to set up a 1.2 GW solar cell manufacturing facility based on TOPCon (Tunnel Oxide Passivated Contact) technology.
- Commercial production is expected to commence by April 2028.
- The entire output is intended for captive consumption by OSEPL's in-house solar module lines.
How the project is proposed to be funded
- Total project cost is estimated at approximately ₹456 crore.
- About ₹296 crore of this is proposed to be funded through debt.
- The balance of ₹159.85 crore is proposed to be funded from the unutilised IPO proceeds of ₹163.04 crore, which were originally earmarked for the Aluminium Frame Facility, the remaining 300 MW EVA Encapsulant Facility and the remaining 500 MW Solar Module Facility, through infusion in OSEPL.
- The Net Proceeds are proposed to be deployed towards the solar cell manufacturing facility by Financial Year 2028.
What the Board approved
- The Board of the Company, in its meeting held today, approved variation in the objects/terms of utilisation of the IPO proceeds and modification of the time limit for the utilisation of the IPO Proceeds.
- This is subject to the receipt of requisite statutory/regulatory approvals, including the approval of the Shareholders of the Company.
Why the company says it chose this route
- The Company evaluated long-term sourcing arrangements with established domestic cell manufacturers, including multi-year off-take commitments. The commercial terms available, covering both pricing and upfront security deposit requirements, were not aligned with the Company's assessment of long-term value or its approach to prudent working capital management.
- A comparative evaluation found that setting up captive cell manufacturing capacity was the more economically viable option.
- The change re-directs IPO capital from what the release describes as a low value-add, deferrable component (frames), surplus module capacity and surplus EVA encapsulant capacity to cell manufacturing.
Capacity context
- At a capacity of 1.2 GW, it will meet approximately 75% of OSEPL's overall cell requirement, with the balance continuing to be sourced externally in the near term.
- Existing and planned module lines (the ~570 MW line plus the 1 GW now being set up) are described as sufficient for current requirements.
Key benefits the company lists
- ALMM List-II compliance: assured access to ALMM-compliant domestic cells for modules supplied under PM-KUSUM, PM Surya Ghar, rooftop and other government-linked projects, protecting the order book eligibility.
- Security of supply: reduced dependence on third-party and imported cells at a time when domestic cell availability is constrained.
- Cost competitiveness: lower input costs and freight, strengthening the position in price-competitive government tenders.
- Technology leadership: TOPCon cells deliver higher efficiency and energy yield, enabling higher-wattage, premium modules.
- Quality control: end-to-end control of cell and module quality, improving reliability and warranty performance of solar pumping systems.
- Execution agility: faster turnaround on large orders, supported by in-house supply of cells and modules.
What to watch
- The variation in the objects of the issue and the modification of the time limit require shareholder approval along with other statutory/regulatory approvals.
- Commercial production is expected by April 2028, so the benefits described are tied to that timeline.
Also from Oswal Pumps
Subsidiary to set up greenfield 1.2 GW solar cell plant; IPO objects varied, timelines extended
10 Oct 2026
More numbers
- Estimated total project cost₹456 crore
- Proposed debt funding₹296 crore
- Balance proposed from unutilised IPO proceeds₹159.85 crore
- Unutilised IPO proceeds re-directed₹163.04 crore
- Cell manufacturing facility capacity1.2 GW
- Share of OSEPL cell requirement to be met75%
Source: BSE · 10 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.